Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Financials out last night

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jun 30, 2023 3:47pm

151 Views

Post# 35522871

RE:RE:Financials out last night

Qtr ending	Milestone Payment	Sales to RF/Abbvie	Other	Total Revenue
Apr 23	0	59,514		59,514
Jan 23	0	0
Oct 22	0	18,055		18,055
Jul 22	640,000	13,868		653,868
Apr 22	0	0		0
Jan 22	0	0		0
Oct 21	0	29,900		29,900
Jul 21	0	29,040		29,040
Apr 21	0	190,923		190,923
Jan 21	0	18,159		18,159
Oct 20	67,225	38,486		105,711
Jul 20	0	0		0
Apr 20	0	0		0
Jan 20	0	0		0
Oct 19	67,225	0	68,518	135,743
Jul 19	0	0		0
Apr 19	0	0		0
Jan 19	0	0	64500	64,500